The mechanism of resistance to sulfa drugs in Plasmodium falciparum.
暂无分享,去创建一个
[1] R. D. Walter,et al. Biosynthesis of Folic Acid Compounds in Plasmodia. Purification and Properties of the 7,8-Dihydropteroate-Synthesizing Enzyme from Plasmodium chabaudi , 2009, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.
[2] J. E. Hyde,et al. Allelic exchange at the endogenous genomic locus in Plasmodium falciparum proves the role of dihydropteroate synthase in sulfadoxine‐resistant malaria , 1998, The EMBO journal.
[3] T. Triglia,et al. Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[4] L. Hall,et al. Mechanism of sulfonamide resistance in clinical isolates of Streptococcus pneumoniae , 1997, Antimicrobial agents and chemotherapy.
[5] J. Champness,et al. Crystal structure of the anti-bacterial sulfonamide drug target dihydropteroate synthase , 1997, Nature Structural Biology.
[6] M. Page,et al. Structure and function of the dihydropteroate synthase from Staphylococcus aureus. , 1997, Journal of molecular biology.
[7] J. E. Hyde,et al. Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization , 1997, Molecular microbiology.
[8] W. Sirawaraporn,et al. Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[9] A. Cowman,et al. Characterization of promoters and stable transfection by homologous and nonhomologous recombination in Plasmodium falciparum. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[10] R. Steketee,et al. Rates and risk factors for mortality during the first two years of life in rural Malawi. , 1996, The American journal of tropical medicine and hygiene.
[11] T. Wellems,et al. Transformation of Plasmodium falciparum malaria parasites by homologous integration of plasmids that confer resistance to pyrimethamine. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[12] O. Sköld,et al. Sulfonamide resistance in Neisseria meningitidis as defined by site-directed mutagenesis could have its origin in other species , 1995, Journal of bacteriology.
[13] J. E. Hyde,et al. Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine. , 1994, European journal of biochemistry.
[14] T. Triglia,et al. Primary structure and expression of the dihydropteroate synthetase gene of Plasmodium falciparum. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[15] W. Wernsdorfer,et al. Plasmodium falciparum: susceptibility in vitro and in vivo to chloroquine and sulfadoxine-pyrimethamine in Ghanaian schoolchildren. , 1994, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[16] Y. Zhang,et al. Inhibition of Plasmodium falciparum dihydropteroate synthetase and growth in vitro by sulfa drugs , 1991, Antimicrobial Agents and Chemotherapy.
[17] M. van der Ploeg,et al. DNA synthesis in Plasmodium berghei during asexual and sexual development. , 1986, Molecular and biochemical parasitology.
[18] J. Inselburg,et al. Plasmodium falciparum: induction, selection, and characterization of pyrimethamine-resistant mutants. , 1986, Experimental parasitology.
[19] A. Jung,et al. Mechanisms of sulfadoxine resistance in Plasmodium falciparum. , 1986, Molecular and biochemical parasitology.
[20] J. Krungkrai,et al. Guanosine triphosphate cyclohydrolase in Plasmodium falciparum and other Plasmodium species. , 1985, Molecular and biochemical parasitology.
[21] W. Peters. The problem of drug resistance in malaria , 1985, Parasitology.
[22] R. Reese,et al. Protein and nucleic acid synthesis during synchronized growth of Plasmodium falciparum , 1984, Journal of bacteriology.
[23] C. Brockelman,et al. Cross resistance of pyrimethamine and sulfadoxine to their related compounds in Plasmodium falciparum. , 1984, Southeast Asian Journal of Tropical Medicine and Public Health.
[24] I. Sherman,et al. Biochemistry of Plasmodium (malarial parasites). , 1979, Microbiological reviews.
[25] R. Ferone. The enzymic synthesis of dihydropteroate and dihydrofolate by Plasmodium berghei. , 1973, The Journal of protozoology.
[26] C. Canfield,et al. Plasmodium knowlesi: in vitro evaluation of antimalarial activity of folic acid inhibitors. , 1971, Experimental parasitology.
[27] W. Gutteridge,et al. Action of pyrimethamine and related drugs against Plasmodium knowlesi in vitro , 1971, Parasitology.
[28] G. Coatney,et al. The influence of antimalarial drugs on nucleic acid synthesis in Plasmodium gallinaceum and Plasmodium berghei. , 1961, Biochemical pharmacology.
[29] I. Rollo. The mode of action of sulphonamides, proguanil and pyrimethamine on Plasmodium gallinaceum. , 1955, British journal of pharmacology and chemotherapy.
[30] A. K. Miller. Folic Acid and Biotin Synthesis by Sulfonamide-sensitive and Sulfonamide-resistant Strains of Escherichia coli. , 1944 .
[31] D. D. Woods. The Relation of p-aminobenzoic Acid to the Mechanism of the Action of Sulphanilamide. , 1940 .
[32] O. Doumbo,et al. P. falciparum dihydrofolate reductase and dihydropteroate synthase mutations: epidemiology and role in clinical resistance to antifolates. , 1998, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[33] B. Nichols,et al. Characterization of a mutationally altered dihydropteroate synthase contributing to sulfathiazole resistance in Escherichia coli. , 1998, Microbial drug resistance.
[34] J. Krungkrai,et al. De novo and salvage biosynthesis of pteroylpentaglutamates in the human malaria parasite, Plasmodium falciparum. , 1989, Molecular and biochemical parasitology.
[35] W. Watkins,et al. Antagonism of sulfadoxine and pyrimethamine antimalarial activity in vitro by p-aminobenzoic acid, p-aminobenzoylglutamic acid and folic acid. , 1985, Molecular and biochemical parasitology.
[36] J. Inselburg,et al. Synthesis of DNA during the asexual cycle of Plasmodium falciparum in culture. , 1984, Molecular and biochemical parasitology.
[37] W. Peters,et al. Antimalarial drugs. II. Current antimalarials and new drug developments. , 1984 .
[38] R. Leimer,et al. Sulphonamides and Sulphones , 1984 .
[39] W. Watkins,et al. The activity of proguanil and its metabolites, cycloguanil and p-chlorophenylbiguanide, against Plasmodium falciparum in vitro. , 1984, Annals of tropical medicine and parasitology.
[40] C. Newbold,et al. Stage specific protein and nucleic acid synthesis during the asexual cycle of the rodent malaria Plasmodium chabaudi. , 1982, Molecular and biochemical parasitology.
[41] R. D. Walter,et al. 7,8-Dihydropteroate-synthesizing enzyme from Plasmodium chabaudi. , 1980, Methods in enzymology.
[42] W. Wernsdorfer,et al. The importance of malaria in the world. , 1980 .
[43] R. Ferone,et al. Folate metabolism in malaria. , 1977, Bulletin of the World Health Organization.
[44] J. McCullough,et al. Dihydropteroate synthetase from Plasmodium berghei: isolation, properties, and inhibition by dapsone and sulfadiazine. , 1974, Molecular pharmacology.